Free Trial
NASDAQ:DCGO

DocGo Q3 2025 Earnings Report

DocGo logo
$1.18 -0.02 (-1.25%)
As of 10:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DocGo EPS Results

Actual EPS
N/A
Consensus EPS
-$0.09
Beat/Miss
N/A
One Year Ago EPS
N/A

DocGo Revenue Results

Actual Revenue
N/A
Expected Revenue
$69.96 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

DocGo Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, November 6, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

DocGo Earnings Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.tc pixel
See More DocGo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DocGo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DocGo and other key companies, straight to your email.

About DocGo

DocGo (NASDAQ:DCGO), Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

View DocGo Profile

More Earnings Resources from MarketBeat